|
시장보고서
상품코드
2056320
면역진단 시장 보고서 : 제품별, 기술별, 용도별, 최종사용자별, 지역별(2026-2034년)Immunodiagnostics Market Report by Product, Technology, Application, End User, and Region 2026-2034 |
||||||
세계의 면역진단 시장 규모는 2025년에 213억 달러에 달했습니다. 향후에 대해 IMARC Group은 2026-2034년에 CAGR 6.25%로 추이하며, 2034년까지 374억 달러에 달할 것으로 예측하고 있습니다.
면역진단은 감염성 질환이나 만성질환의 검출을 위해 항원-항체 반응을 이용하는 체외진단 기술을 말합니다. 여기에는 방사선, 형광 또는 발색 효소 및 프로브를 사용하여 질병의 진행을 식별하기 위해 표적 범위를 확장하는 데 도움이 되는 항체를 식별하는 것이 포함됩니다. 또한 면역진단에서는 효소면역측정법(ELISA), 화학발광법, 방사성동위원소 분석, 신속검사를 위해 다양한 시약, 기기 및 소프트웨어 기반 솔루션이 사용되고 있습니다. 이러한 솔루션은 암, 자가면역질환, 호흡기질환, 내분비질환, 종양성 질환 등의 질병 진단뿐만 아니라 법의학, 환경분석, 식품분석 등에도 널리 활용되고 있습니다. 그 결과, 면역진단은 병원, 임상검사실, 연구기관 및 학술기관 등 다양한 분야에서 활용되고 있습니다.
면역진단 시장 동향:
일반 시민들 사이에서 만성질환 및 감염성 질환의 유병률이 증가하고 있는 것이 시장 성장을 이끄는 주요 요인 중 하나입니다. 또한 이러한 질병에 걸리기 쉬운 고령 인구의 증가도 시장 성장을 촉진하고 있습니다. 또한 B형 간염, 당뇨병, 암 등의 질병에 대한 치료 옵션에 대한 소비자의 인식이 높아지면서 면역진단 키트, 분석기, 분석기 수요에 긍정적인 영향을 미치고 있습니다. 또한 차세대 면역진단 플랫폼 개발 등 다양한 기술 발전이 시장 성장을 촉진할 것으로 예상됩니다. 이러한 첨단 현장진단(POCT) 시스템은 패혈증, 급성 심근경색 및 기타 사망률이 높은 질병에 대해 보다 높은 수준의 진단 기능을 제공합니다. 이 밖에도 일반인들의 맞춤형 의료에 대한 수요 증가, 특히 개발도상국의 의료 인프라의 대폭적인 개선 등도 시장 성장을 촉진할 것으로 예상됩니다.
이 보고서에서 답변하는 주요 질문
- 세계 면역진단 시장 규모는 어느 정도인가?
- 2026-2034년 세계의 면역진단 시장의 예상 성장률은 어느 정도인가?
- 세계의 면역 진단 시장을 촉진하는 주요 요인은 무엇인가?
- COVID-19는 세계의 면역진단 시장에 어떤 영향을 미쳤는가?
- 용도별 세계의 면역진단 시장은 어떻게 구성되어 있는가?
- 세계의 면역진단 시장은 최종사용자별로 어떻게 분류이 이루어지고 있는가?
- 세계 면역진단 시장의 주요 지역은 어디인가?
- 세계의 면역진단 시장의 주요 플레이어/기업은?
목차
제1장 서문
제2장 조사 범위와 조사 방법
제3장 개요
제4장 서론
제5장 세계의 면역진단 시장
제6장 시장 내역 : 제품별
제7장 시장 내역 : 기술별
제8장 시장 내역 : 용도별
제9장 시장 내역 : 최종사용자별
제10장 시장 내역 : 지역별
제11장 SWOT 분석
제12장 밸류체인 분석
제13장 Porter's Five Forces 분석
제14장 가격 분석
제15장 경쟁 구도
KSA 26.06.16The global immunodiagnostics market size reached USD 21.3 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 37.4 Billion by 2034, exhibiting a growth rate (CAGR) of 6.25% during 2026-2034.
Immunodiagnostics refers to an in-vitro diagnostic technology that uses antigen-antibody reaction for the detection of infectious and chronic diseases. It involves the use of radiological, fluorescent or color-forming enzymes and probes for the identification of antibodies that aid in enhancing the targeting range to identify disease progression. Immunodiagnostics also uses various reagents, instruments and software-based solutions for enzyme-linked immunosorbent assay, chemiluminescence, radioimmunoassay and rapid testing. These solutions are widely used for diagnosing diseases, such as cancer and autoimmune, respiratory, endocrine and oncological disorders, along with forensic psychology and environmental and food analysis. As a result, immunodiagnostics finds extensive applications across hospitals, clinical laboratories and research and academic institutes.
Immunodiagnostics Market Trends:
The increasing prevalence of chronic medical ailments and infections among the masses is one of the key factors driving the market growth. Moreover, the rising geriatric population, which is more susceptible to such ailments, is providing a thrust to the growth of the market. There is also an escalating awareness among the consumers regarding the available treatment alternatives for ailments, such as hepatitis B, diabetes and cancer, which is positively impacting the demand for immunodiagnostics kits, assays and analyzers. Additionally, various technological advancements, such as the development of next-generation immunodiagnostics platforms, are anticipated to drive the market toward growth. These advanced point-of-care testing (POCT) systems offer enhanced diagnostic facilities for sepsis, acute cardiac infractions and other medical disorders with higher mortality rates. Other factors, including the increasing requirement for personalized medicines among the masses, along with extensive improvements in the healthcare infrastructure, especially in the developing economies, are anticipated to drive the market toward growth.
Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the global immunodiagnostics market report, along with forecasts at the global, regional and country level from 2026-2034. Our report has categorized the market based on product, technology, application and end user.
Breakup by Product:
- Reagents
- Instruments
- Software and Services
Breakup by Technology:
- Enzyme-Linked Immunosorbent Assay
- Chemiluminescence Immunoassay
- Fluorescent Immunoassay
- Radioimmunoassay
- Rapid Test
- Others
Breakup by Application:
- Infectious Diseases
- Oncology and Endocrinology
- Hepatitis and Retrovirus
- Bone and Mineral
- Autoimmunity
- Cardiac Biomarker
- Others
Breakup by End User:
- Hospitals
- Clinical Laboratories
- Academic and Research Centers
- Pharmaceutical and Biotechnology Industry
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Arkray Inc., bioMerieux SA, Bio-Rad Laboratories Inc., DiaSorin S.p.A., F. Hoffmann-La Roche AG, Immunodiagnostic Systems Holdings PLC, Johnson & Johnson, Siemens AG, Sysmex Corporation and Thermo Fisher Scientific Inc.
Key Questions Answered in This Report
- 1.How big is the global immunodiagnostics market?
- 2.What is the expected growth rate of the global immunodiagnostics market during 2026-2034?
- 3.What are the key factors driving the global immunodiagnostics market?
- 4.What has been the impact of COVID-19 on the global immunodiagnostics market?
- 5.What is the breakup of the global immunodiagnostics market based on the application?
- 6.What is the breakup of the global immunodiagnostics market based on the end user?
- 7.What are the key regions in the global immunodiagnostics market?
- 8.Who are the key players/companies in the global immunodiagnostics market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Immunodiagnostics Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 Reagents
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Instruments
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Software and Services
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
7 Market Breakup by Technology
- 7.1 Enzyme-Linked Immunosorbent Assay
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Chemiluminescence Immunoassay
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Fluorescent Immunoassay
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Radioimmunoassay
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Rapid Test
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
- 7.6 Others
- 7.6.1 Market Trends
- 7.6.2 Market Forecast
8 Market Breakup by Application
- 8.1 Infectious Diseases
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Oncology and Endocrinology
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Hepatitis and Retrovirus
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Bone and Mineral
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 8.5 Autoimmunity
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
- 8.6 Cardiac Biomarker
- 8.6.1 Market Trends
- 8.6.2 Market Forecast
- 8.7 Others
- 8.7.1 Market Trends
- 8.7.2 Market Forecast
9 Market Breakup by End User
- 9.1 Hospitals
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Clinical Laboratories
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Academic and Research Centers
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
- 9.4 Pharmaceutical and Biotechnology Industry
- 9.4.1 Market Trends
- 9.4.2 Market Forecast
- 9.5 Others
- 9.5.1 Market Trends
- 9.5.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.1.1 United States
- 10.2 Asia-Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.2.1 China
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.3.1 Germany
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.4.1 Brazil
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Abbott Laboratories
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.1.3 Financials
- 15.3.1.4 SWOT Analysis
- 15.3.2 Arkray Inc.
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.3 bioMerieux SA
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.3.3 Financials
- 15.3.3.4 SWOT Analysis
- 15.3.4 Bio-Rad Laboratories Inc.
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.4.3 Financials
- 15.3.4.4 SWOT Analysis
- 15.3.5 DiaSorin S.p.A.
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.5.3 Financials
- 15.3.5.4 SWOT Analysis
- 15.3.6 F. Hoffmann-La Roche AG
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.6.3 Financials
- 15.3.7 Immunodiagnostic Systems Holdings PLC
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.7.3 Financials
- 15.3.8 Johnson & Johnson
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.8.3 Financials
- 15.3.8.4 SWOT Analysis
- 15.3.9 Siemens AG
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.10 Sysmex Corporation
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.10.3 Financials
- 15.3.10.4 SWOT Analysis
- 15.3.11 Thermo Fisher Scientific Inc.
- 15.3.11.1 Company Overview
- 15.3.11.2 Product Portfolio
- 15.3.11.3 Financials
- 15.3.11.4 SWOT Analysis
- 15.3.1 Abbott Laboratories
